Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023

Rhea-AI Summary

Champions Oncology, Inc. (CSBR) will report its third-quarter financial results for the period ending January 31, 2023, on March 15, 2023, after market close. Additionally, the company will host a conference call at 4:30 P.M. EDT to discuss these results. Interested parties can participate by calling 888-506-0062 (Domestic) or 973-528-0011 (International). A replay of the call will be accessible shortly after the event. Champions Oncology specializes in AI-driven drug discovery and provides innovative therapeutic and research solutions to biopharma clients.

Positive

• Champions Oncology's AI-driven approach to drug discovery positions it well in the biotech sector.
• The company engages in innovative therapeutics and has a strong focus on R&D services.

Negative

• None.

HACKENSACK, NJ / ACCESSWIRE / March 13, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the third quarter ended January 31, 2023, on Wednesday, March 15, 2023, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 500542. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 47846, or by accessing the investors section of the company's website within 72 hours.

About Champions Oncology, Inc.

Champions Oncology is a technology-driven research organization that develops innovative therapeutics against cancer targets, offers groundbreaking research software as a service, and provides end-to-end R&D services to biopharma organizations. Champions Oncology is actively engaged in the transformation of drug discovery through a novel approach of pharmaco-pheno-multiomic integration. For more information, please visit www.ChampionsOncology.com.

SOURCE: Champions Oncology, Inc.

View source version on accesswire.com:
https://www.accesswire.com/743362/Champions-Oncology-to-Announce-Third-Quarter-Financial-Results-on-Wednesday-March-15-2023

FAQ

When will Champions Oncology announce its Q3 results?

Champions Oncology will announce its third-quarter results on March 15, 2023.

What is the stock symbol for Champions Oncology?

The stock symbol for Champions Oncology is CSBR.

What time is the Champions Oncology conference call?

The Champions Oncology conference call will take place at 4:30 P.M. EDT on March 15, 2023.

How can I listen to the Champions Oncology earnings call?

To listen to the earnings call, dial 888-506-0062 for domestic calls or 973-528-0011 for international calls.